Concepedia

Publication | Open Access

CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma

DOIFull Paper Access

16

Citations

44

References

2016

Year

Casey E. Gooden, Patricia Jones, Ruth E. Bates, Wendy Shallenberger, Urvashi Surti, Steven H. Swerdlow, Christine G. Roth
Cytometry Part B Clinical Cytometry

Abstract

CD49d is a robust adverse prognostic marker in CLL/SLL with superior performance characteristics. © 2016 International Clinical Cytometry Society.

References

YearCitations

Page 1